Department of Surgery II, Faculty of Medicine, Yamagata University, Yamagata, Japan.
Department of Pathological Diagnostics, Faculty of Medicine, Yamagata University, Yamagata, Japan.
Thorac Cardiovasc Surg. 2022 Apr;70(3):233-238. doi: 10.1055/s-0040-1722172. Epub 2021 Feb 4.
We aimed to retrospectively compare the long-term prognosis and recurrence after segmentectomy between nonsmall cell lung cancer (NSCLC) patients with deep and peripheral lesions.
Data were extracted for 85 lobectomy-tolerable NSCLC patients with tumors measuring ≤2 cm, who underwent video-assisted thoracoscopic segmentectomy with curative intent during January 2006 to December 2014. Tumor location was determined by the surgeon using thin-slice (1 mm) and three-dimensional computed tomography. Overall and recurrence-free survival was compared between patients with peripheral and deep lesions using univariate and multivariate Cox proportional hazard models. The indications for segmentectomy included NSCLC measuring ≤2 cm and consolidation/tumor ratio ≤20%, solid NSCLC ≤1 cm, and indeterminate nodule ≤1.5 cm.
No recurrence of peripheral and deep lesions was noted. The 5-year overall survival was 96.4% for all patients, and 100 and 95.3% for patients with deep and peripheral lesions, respectively. There was no significant difference between the overall survival rates associated with the deep and peripheral lesions (95% confidence interval [CI], 89.5-98.8, nonsignificant, 86.4-98.4, respectively; = 0.189). In a multivariate analysis, the American Society of Anesthesiologists score (hazard ratio [HR], 13.30; 95% CI, 1.31-210.36; = 0.028) and histology (HR, 0.03; 95% CI, 0.00-0.32; = 0.037) were independent prognostic factors for overall survival; tumor location was not a prognostic factor.
When video-assisted thoracoscopic segmentectomy with curative intent was performed with sufficient surgical margins, the location of small NSCLC did not affect recurrence risk and prognosis. Video-assisted thoracoscopic segmentectomy for small NSCLC is acceptable, regardless of the tumor location.
本研究旨在回顾性比较非小细胞肺癌(NSCLC)患者中深部位和外周部位病变行肺段切除术的长期预后和复发情况。
选取 2006 年 1 月至 2014 年 12 月期间行电视辅助胸腔镜肺段切除术且肿瘤直径≤2cm 的 85 例可耐受肺叶切除术的 NSCLC 患者,提取其临床资料。通过薄层(1mm)和三维 CT 由外科医生确定肿瘤位置。使用单因素和多因素 Cox 比例风险模型比较外周部和深部病变患者的总生存率和无复发生存率。肺段切除术的适应证包括 NSCLC 直径≤2cm,实变/肿瘤比值≤20%,实性 NSCLC 直径≤1cm,不确定结节直径≤1.5cm。
未观察到外周部和深部病变的复发。所有患者的 5 年总生存率为 96.4%,深部病变和外周病变患者的 5 年总生存率分别为 100%和 95.3%。深部病变与外周病变的总生存率无显著差异(95%可信区间[CI],89.5%-98.8%,无统计学意义,86.4%-98.4%, = 0.189)。多因素分析显示,美国麻醉医师协会评分(危险比[HR],13.30;95%CI,1.31-210.36; = 0.028)和组织学(HR,0.03;95%CI,0.00-0.32; = 0.037)是总生存率的独立预后因素;肿瘤位置不是预后因素。
当行根治性电视辅助胸腔镜肺段切除术且有足够的手术切缘时,小的 NSCLC 位置并不影响复发风险和预后。对于小的 NSCLC,无论肿瘤位置如何,行电视辅助胸腔镜肺段切除术都是可以接受的。